纳斯达克生物技术指数ETF-iShares IBB 深 沪
等待开盘 08-19 09:30:00 美东时间
138.795
+0.035
+0.03%
华盛通- 最 高139.68
- 今 开139.00
- 成交量 73.35万股
- 最 低 138.61
- 昨 收 138.76
- 总市值 58.43亿
- 52周最高 150.181
- 市盈率 静 --
- 换手率 1.74%
- 52周最低 107.43
- 委 比 -25.57%
- 总股本 4210.00万
- 历史最高 175.9383
- 量 比 0.55
- 振 幅 0.77%
- 历史最低 77.2281
- 每 手 1
- 风险率 8.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多港股创新药精选ETF(520690)今重磅上市！三重引擎驱动创新药黄金周期，掘金千亿老龄化需求+技术出海红利
隔夜美股三大指数收跌，中概指数涨0.66%。港股三大指数小幅低开，恒指跌0.12%，国指跌0.14%，恒生科技指数跌0.09%。盘面上，创新药概念股部分下跌，百...
08-01 10:40
SA Quant's top healthcare picks amid Q2 earnings season
The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of 12.12% in the S&P 500 index, fell 0.91% so far this year, compared to 6.78% r...
07-11 21:35
Liberty Broadband Spin-Off Of GCI Liberty Set For July 14, 2025; When-Issued Trading Begins July 11, 2025 Under "GLBAV" & "GLBKV", Regular Trading Starts July 15, 2025 On Nasdaq
Liberty Broadband Corporation ("Liberty Broadband") (NASDAQ:LBRDA, LBRDK, LBRDP))), announced today that, in connection with its upcoming spin-off (the "Spin-Off") of its wholly owned subsidiary GCI Liberty, Inc. ("GCI
07-11 04:33
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment
Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall.
05-19 22:35
Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Tim Seymour of Seymour Asset Management picked Cameco Corporation.
2024-11-18 21:55
美股降息“万金油”交易！生物医药板块胜率、赔率大幅领跑，入场时机已到？
美联储首次降息倒数19天！如何抢跑布局低利率时代的投资机会？华尔街看好生物医药板块性价比，一文看懂投资逻辑>>
2024-08-30 23:03
US Stocks Bounce; Chipmakers, Cruise Lines Lead, Dollar Falls: What's Driving Markets Thursday?
On Thursday, Wall Street rebounded into positive territory, following a brief dip experienced on Wednesday. At midday trading New York time, all major stock indices were trading in the green as traders prepared for the final trading week of the year.
2023-12-22 03:11
Activist Investor Elliott Pushes for Strategy Revamp at BioMarin Amid CEO Change
Activist investor Elliott Investment Management has taken a significant position in BioMarin Pharmaceutical Inc (NASDAQ: BMRN), engaging with the company on its strategic direction amid leadership changes and the evolving status of its
2023-11-08 05:12
